BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Barchi LC, Ramos MFKP, Dias AR, Forones NM, Carvalho MP, Castro OAP, Kassab P, Costa-Júnior WLD, Weston AC, Zilberstein B, Ferraz ÁAB, ZeideCharruf A, Brandalise A, Silva AMD, Alves B, Marins CAM, Malheiros CA, Leite CV, Bresciani CJC, Szor D, Mucerino DR, Wohnrath DR, JirjossIlias E, Martins Filho ED, PinatelLopasso F, Coimbra FJF, Felippe FEC, Tomasisch FDS, Takeda FR, Ishak G, Laporte GA, Silva HJT, Cecconello I, Rodrigues JJG, Grande JCD, Lourenço LG, Motta LMD, Ferraz LR, Moreira LF, Lopes LR, Toneto MG, Mester M, Rodrigues MAG, Franciss MY, AdamiAndreollo N, Corletta OC, Yagi OK, Malafaia O, Assumpção PP, Savassi-Rocha PR, Colleoni Neto R, Oliveira RJ, AissarSallun RA, Weschenfelder R, Oliveira SCV, Abreu TB, Castria TB, Ribeiro Junior U, Barra W, Freitas Júnior WR; Consenso. BRAZILIAN GASTRIC CANCER ASSOCIATION GUIDELINES (PART 2): UPDATE ON TREATMENT. Arq Bras Cir Dig 2021;34:e1563. [PMID: 34008707 DOI: 10.1590/0102-672020210001e1563] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Arneiro AJ, Ramos MFKP, Pereira MA, Dias AR, Zilberstein B, Ribeiro Junior U, Nahas SC. Impact of COVID-19 pandemic on the surgical treatment of gastric cancer. Clinics (Sao Paulo) 2021;76:e3508. [PMID: 34852144 DOI: 10.6061/clinics/2021/e3508] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Castro JSL, Pelosof AG, Andrade-Cabral JGG, Seraphim AM, Taglieri E, Coimbra FJF, Zitron C. ENDOSCOPIC CHARACTERISTICS OF PATIENTS WITH COMPLETE PATHOLOGICAL RESPONSE AFTER NEOADJUVANT CHEMOTHERAPY FOR GASTRIC AND ESOPHAGOGASTRIC JUNCTION ADENOCARCINOMAS. Arq Bras Cir Dig 2022;34:e1616. [PMID: 35019128 DOI: 10.1590/0102-672020210002e1616] [Reference Citation Analysis]